Teropavimab: Clinical Trials

3 trials of Teropavimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting, 1 suspended. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 1, Not yet recruiting 1, Suspended 1
Phase 11Suspended 1
Phase 31Not yet recruiting 1

Follow Teropavimab: new trials by email Literature Review of Teropavimab trials Research Report on Teropavimab

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Twice Yearly Lenacapavir, Teropavimab, and Zinlirvimab in the Pediatric Population With HIV-1
Lenacapavir Tablet, Lenacapavir Injection, Teropavimab - HIV-1-infection
Phase 2 / Phase 3Not yet recruitingGilead Sciences252026-11-012026-11-19
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3 - HIV-1-infection
Phase 1 / Phase 2SuspendedNational Institute of Allergy and Infectious Diseases (NIAID)362024-04-012026-09-02
A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection
Teropavimab, Zinlirvimab, Lenacapavir Tablet - HIV-1 Infection
Phase 2Active not recruitingGilead Sciences832023-05-152026-04-27

Sponsors

Gilead Sciences (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (3)  ·  Australia (1)  ·  Brazil (1)  ·  Canada (1)  ·  Puerto Rico (1)

Top investigators

Sharon Riddler, MD, MPH (1)

Results publications

PMID 41720146